Caprylic acid (from Latin capra 'goat'), also known under the systematic name octanoic acid or C8 Acid, is a saturated fatty acid, medium-chain fatty acid (MCFA). It has the structural formula H3C−(CH2)6−COOH, and is a colorless oily liquid that is minimally soluble in water with a slightly unpleasant rancid-like smell and taste. Salts and esters of octanoic acid are known as octanoates or caprylates. The name of the related acyl group is octanoyl, capryloyl, or caprylyl. It is a common industrial chemical, which is produced by oxidation of the C8 aldehyde. Its compounds are found naturally in the milk of various mammals and as a minor constituent of coconut oil and palm kernel oil.
Two other acids are named after goats via the Latin word capra: caproic acid (C6) and capric acid (C10). Together, these three fatty acids comprise 15% of the fatty acids in goat milk fat. |
Read full article at Wikipedia
|
InChI=1S/C18H21NO4/c1- 19- 8- 7- 17- 14- 10- 3- 4- 12(22- 2) 15(14) 23- 16(17) 11(20) 5- 6- 18(17,21) 13(19) 9- 10/h3- 4,13,16,21H,5- 9H2,1- 2H3/t13- ,16+,17+,18- /m1/s1 |
BRUQQQPBMZOVGD-XFKAJCMBSA-N |
COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O |
|
opioid analgesic
A narcotic or opioid substance, synthetic or semisynthetic agent producing profound analgesia, drowsiness, and changes in mood.
mu-opioid receptor agonist
A compound that exhibits agonist activity at the mu-opioid receptor.
|
|
opioid analgesic
A narcotic or opioid substance, synthetic or semisynthetic agent producing profound analgesia, drowsiness, and changes in mood.
mu-opioid receptor agonist
A compound that exhibits agonist activity at the mu-opioid receptor.
antitussive
An agent that suppresses cough. Antitussives have a central or a peripheral action on the cough reflex, or a combination of both. Compare with expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing, and mucolytics, which decrease the viscosity of mucus, facilitating its removal by ciliary action and expectoration.
|
|
View more via ChEBI Ontology
14-hydroxy-3-methoxy-17-methyl-4,5α-epoxymorphinan-6-one
|
oxicodona
|
WHO MedNet
|
oxycodone
|
WHO MedNet
|
oxycodone
|
ChemIDplus
|
oxycodonum
|
WHO MedNet
|
(-)-14-Hydroxydihydrocodeinone
|
ChemIDplus
|
4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
|
ChemIDplus
|
4,5α-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
|
ChemIDplus
|
Dihydro-14-hydroxycodeinone
|
ChemIDplus
|
Dihydrohydroxycodeinone
|
ChemIDplus
|
Dihydroxycodeinone
|
ChemIDplus
|
Oxycodone
|
KEGG COMPOUND
|
2029
|
DrugCentral
|
C08018
|
KEGG COMPOUND
|
D05312
|
KEGG DRUG
|
DB00497
|
DrugBank
|
Oxycodone
|
Wikipedia
|
View more database links |
43446
|
Beilstein Registry Number
|
Beilstein
|
76-42-6
|
CAS Registry Number
|
ChemIDplus
|
27093887
|
PubMed citation
|
Europe PMC
|
27873179
|
PubMed citation
|
Europe PMC
|
27921252
|
PubMed citation
|
Europe PMC
|
28074831
|
PubMed citation
|
Europe PMC
|
28080998
|
PubMed citation
|
Europe PMC
|
28107783
|
PubMed citation
|
Europe PMC
|
28127624
|
PubMed citation
|
Europe PMC
|
28170358
|
PubMed citation
|
Europe PMC
|
28194654
|
PubMed citation
|
Europe PMC
|
28205004
|
PubMed citation
|
Europe PMC
|
|